Overview
Bilateral renal agenesis (BRA), also known as Potter syndrome or Potter sequence, is a severe congenital condition characterized by the complete absence of both kidneys at birth. This condition arises from a failure of kidney development during embryogenesis. Without functioning kidneys, the fetus cannot produce urine, which is the primary contributor to amniotic fluid during the second and third trimesters of pregnancy. The resulting severe oligohydramnios (critically low amniotic fluid) leads to a cascade of secondary abnormalities collectively known as Potter sequence, including pulmonary hypoplasia (underdeveloped lungs), characteristic facial features (flattened nose, recessed chin, low-set ears), and limb abnormalities due to compression in utero. Bilateral renal agenesis is a lethal condition in the vast majority of cases. Affected infants are typically stillborn or die within hours to days after birth, primarily due to respiratory failure caused by severely underdeveloped lungs. The condition can be detected prenatally through ultrasound, which may reveal absent kidneys and severe oligohydramnios, typically becoming apparent in the second trimester. Additional prenatal findings may include absence of the fetal bladder. The condition affects the urogenital system broadly, and associated anomalies of the genital tract, cardiovascular system, gastrointestinal tract, and musculoskeletal system may also be present. Bilateral renal agenesis can occur as an isolated finding or as part of a broader genetic syndrome. It may arise sporadically or follow an autosomal dominant pattern with incomplete penetrance and variable expressivity, particularly in familial cases linked to mutations in genes such as RET, FGF20, or ITGA8. Some cases are associated with autosomal recessive inheritance. Currently, there is no curative treatment. Management is primarily supportive and palliative. Experimental approaches including serial amnioinfusion during pregnancy and postnatal peritoneal dialysis followed by kidney transplantation have been explored in a very limited number of cases, but these remain investigational and outcomes are uncertain. Genetic counseling is recommended for affected families, as first-degree relatives may carry unilateral renal agenesis or other renal anomalies.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Renal agenesis, bilateral.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Renal agenesis, bilateral at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Renal agenesis, bilateral.
Community
No community posts yet. Be the first to share your experience with Renal agenesis, bilateral.
Start the conversation →Latest news about Renal agenesis, bilateral
No recent news articles for Renal agenesis, bilateral.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Renal agenesis, bilateral
What is Renal agenesis, bilateral?
Bilateral renal agenesis (BRA), also known as Potter syndrome or Potter sequence, is a severe congenital condition characterized by the complete absence of both kidneys at birth. This condition arises from a failure of kidney development during embryogenesis. Without functioning kidneys, the fetus cannot produce urine, which is the primary contributor to amniotic fluid during the second and third trimesters of pregnancy. The resulting severe oligohydramnios (critically low amniotic fluid) leads to a cascade of secondary abnormalities collectively known as Potter sequence, including pulmonary h
At what age does Renal agenesis, bilateral typically begin?
Typical onset of Renal agenesis, bilateral is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Renal agenesis, bilateral?
2 specialists and care centers treating Renal agenesis, bilateral are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.